4//SEC Filing
Rosenberg Noah L. 4
Accession 0001579649-25-000004
CIK 0001660334other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 7:00 PM ET
Size
7.5 KB
Accession
0001579649-25-000004
Insider Transaction Report
Form 4
Transactions
- Purchase
Series C Warrant (right to buy)
2025-11-25+589→ 589 totalExercise: $6.32Exp: 2030-11-25→ Common Stock (589 underlying) - Purchase
Common Stock
2025-11-25$4.24/sh+2,357$10,000→ 2,357 total
Footnotes (2)
- [F1]Immediately exercisable.
- [F2]The reported securities are included within 2,357 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001579649
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 7:00 PM ET
- Size
- 7.5 KB